METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER

Clinical trials for METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER trials appear

Sign up with your email to follow new studies for METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 4 Not yet finished but already full! 1

New drug combo shows promise in Hard-to-Treat breast cancer

Disease control Ongoing

This early-stage trial is testing whether adding an experimental drug called Ipatasertib to standard hormone therapy can help control metastatic hormone receptor positive breast cancer. The study involves 77 women whose cancer has spread and is no longer responding to usual treat…

Matched conditions: METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER

Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control

Last updated Jun 22, 2026 11:55 UTC

METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER

Get alerted when new METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER trials appear

New drug combo shows promise in Hard-to-Treat breast cancer